Dr Jonathan Ball
Research Fellow


I joined Exeter University from AstraZeneca as part of the Zebrafish Research team which was relocated from the Brixham site in May 2014.

I have considerable experience of environmental toxicology from my Ph.D and post-doctoral research on the effects of Ethinyl oestradiol on gene expression and sexual development of the Zebrafish, and investigating the effects of environmental pollutants, respectively.

For the last 7 years I have been working in external commercial industry using the Zebrafish as a toxicity model. For the last 5 years I have been based at Brixham working for AstraZeneca.

At AstraZeneca I was the technical lead for non-mammalian alternatives for the assessment of Developmental Toxicology.  Recognised as an industry expert and the industry technical lead for an international consortium of five leading pharmaceutical companies (AZ, Pfizer, BMS, Amgen and Abbott), who joined forces to standardise the Zebrafish Developmental toxicity assay. 

Initiated and led the training of technical experts across the consortia.  Supporting a new research collaboration to identify novel complimentary techniques using the Zebrafish model, to extend its application and to encourage wider acceptance and usage within industry.  Use my knowledge and expertise to support research colleagues in the development of other novel zebrafish assays for the assessment of human safety.

Broad research specialisms:

  • Zebrafish
  • Developmental toxicity
  • Environmental safety
  • Human safety


1996-2000 B.Sc., Biochemistry, Cardiff University
2000-2004 Ph.D., Biology, Exeter University

Contact details

Internal tel6237
Tel+44 (0) 1392 726237
AddressHatherly Building
University of Exeter
Prince of Wales Road

Back | Top of page | Edit Profile | Refresh page